US Stock MarketDetailed Quotes

Nurix Therapeutics (NRIX)

Watchlist
  • 16.690
  • -0.280-1.65%
Close Apr 16 16:00 ET
  • 16.690
  • 0.0000.00%
Post 17:17 ET
1.73BMarket Cap-5.26P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Nurix Therapeutics (NRIX) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Feb 28, 2026
(FY)Nov 30, 2025
(Q4)Nov 30, 2025
(Q3)Aug 31, 2025
(Q2)May 31, 2025
(Q1)Feb 28, 2025
(FY)Nov 30, 2024
(Q4)Nov 30, 2024
(Q3)Aug 31, 2024
(Q2)May 31, 2024
Total revenue
-66.12%6.25M
53.95%83.98M
2.21%13.58M
-37.29%7.89M
264.34%44.06M
11.26%18.45M
-29.15%54.55M
-12.37%13.28M
-31.84%12.59M
-60.58%12.09M
Operating revenue
-66.12%6.25M
53.95%83.98M
2.21%13.58M
-37.29%7.89M
264.34%44.06M
11.26%18.45M
-29.15%54.55M
-12.37%13.28M
-31.84%12.59M
-60.58%12.09M
Cost of revenue
Gross profit
Operating expense
21.43%98.75M
38.15%369.65M
24.03%96.67M
47.74%99.28M
52.36%92.38M
31.57%81.32M
15.31%267.58M
28.84%77.94M
14.91%67.2M
5.56%60.63M
Selling and administrative expenses
25.36%14.61M
14.80%52.74M
27.35%13.65M
12.30%13.16M
21.96%14.28M
-1.23%11.65M
7.09%45.94M
-0.58%10.72M
10.31%11.72M
0.27%11.71M
-General and administrative expense
25.36%14.61M
14.80%52.74M
27.35%13.65M
12.30%13.16M
21.96%14.28M
-1.23%11.65M
7.09%45.94M
-0.58%10.72M
10.31%11.72M
0.27%11.71M
Research and development costs
20.78%84.14M
42.99%316.9M
23.50%83.02M
55.22%86.12M
59.63%78.1M
39.31%69.66M
17.17%221.63M
35.22%67.22M
15.93%55.48M
6.90%48.92M
Operating profit
-47.14%-92.5M
-34.10%-285.67M
-28.52%-83.1M
-67.34%-91.39M
0.45%-48.32M
-39.02%-62.86M
-37.38%-213.03M
-42.62%-64.66M
-36.49%-54.61M
-81.36%-48.54M
Net non-operating interest income expense
-18.30%5.32M
11.36%21.97M
-20.31%4.87M
-13.47%4.96M
37.56%5.62M
71.80%6.51M
77.49%19.73M
81.05%6.12M
89.34%5.74M
64.15%4.08M
Non-operating interest income
-18.30%5.32M
11.36%21.97M
-20.31%4.87M
-13.47%4.96M
37.56%5.62M
71.80%6.51M
77.49%19.73M
81.05%6.12M
89.34%5.74M
64.15%4.08M
Other net income (expense)
Income before tax
-54.70%-87.17M
-36.42%-263.7M
-33.62%-78.22M
-76.82%-86.42M
3.94%-42.7M
-36.02%-56.35M
-34.28%-193.3M
-39.53%-58.54M
-32.16%-48.87M
-83.12%-44.46M
Income tax
181.48%760K
0
0
744.44%760K
0
270K
8K
82K
90K
Net income
-54.70%-87.17M
-36.62%-264.46M
-33.60%-78.22M
-76.53%-86.42M
2.43%-43.46M
-35.73%-56.35M
-34.47%-193.57M
-39.55%-58.55M
-32.38%-48.96M
-83.49%-44.55M
Net income continuous Operations
-54.70%-87.17M
-36.62%-264.46M
-33.60%-78.22M
-76.53%-86.42M
2.43%-43.46M
-35.73%-56.35M
-34.47%-193.57M
-39.55%-58.55M
-32.38%-48.96M
-83.49%-44.55M
Minority interest income
Net income attributable to the parent company
-54.70%-87.17M
-36.62%-264.46M
-33.60%-78.22M
-76.53%-86.42M
2.43%-43.46M
-35.73%-56.35M
-34.47%-193.57M
-39.55%-58.55M
-32.38%-48.96M
-83.49%-44.55M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-54.70%-87.17M
-36.62%-264.46M
-33.60%-78.22M
-76.53%-86.42M
2.43%-43.46M
-35.73%-56.35M
-34.47%-193.57M
-39.55%-58.55M
-32.38%-48.96M
-83.49%-44.55M
Basic earnings per share
-17.91%-0.79
-5.90%-3.05
-9.33%-0.82
-53.73%-1.03
26.76%-0.52
11.84%-0.67
-8.68%-2.88
2.60%-0.75
1.47%-0.67
-57.78%-0.71
Diluted earnings per share
-17.91%-0.79
-5.90%-3.05
-9.33%-0.82
-53.73%-1.03
26.76%-0.52
11.84%-0.67
-8.68%-2.88
2.60%-0.75
1.47%-0.67
-57.78%-0.71
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
(Q1)Feb 28, 2026(FY)Nov 30, 2025(Q4)Nov 30, 2025(Q3)Aug 31, 2025(Q2)May 31, 2025(Q1)Feb 28, 2025(FY)Nov 30, 2024(Q4)Nov 30, 2024(Q3)Aug 31, 2024(Q2)May 31, 2024
Total revenue -66.12%6.25M53.95%83.98M2.21%13.58M-37.29%7.89M264.34%44.06M11.26%18.45M-29.15%54.55M-12.37%13.28M-31.84%12.59M-60.58%12.09M
Operating revenue -66.12%6.25M53.95%83.98M2.21%13.58M-37.29%7.89M264.34%44.06M11.26%18.45M-29.15%54.55M-12.37%13.28M-31.84%12.59M-60.58%12.09M
Cost of revenue
Gross profit
Operating expense 21.43%98.75M38.15%369.65M24.03%96.67M47.74%99.28M52.36%92.38M31.57%81.32M15.31%267.58M28.84%77.94M14.91%67.2M5.56%60.63M
Selling and administrative expenses 25.36%14.61M14.80%52.74M27.35%13.65M12.30%13.16M21.96%14.28M-1.23%11.65M7.09%45.94M-0.58%10.72M10.31%11.72M0.27%11.71M
-General and administrative expense 25.36%14.61M14.80%52.74M27.35%13.65M12.30%13.16M21.96%14.28M-1.23%11.65M7.09%45.94M-0.58%10.72M10.31%11.72M0.27%11.71M
Research and development costs 20.78%84.14M42.99%316.9M23.50%83.02M55.22%86.12M59.63%78.1M39.31%69.66M17.17%221.63M35.22%67.22M15.93%55.48M6.90%48.92M
Operating profit -47.14%-92.5M-34.10%-285.67M-28.52%-83.1M-67.34%-91.39M0.45%-48.32M-39.02%-62.86M-37.38%-213.03M-42.62%-64.66M-36.49%-54.61M-81.36%-48.54M
Net non-operating interest income expense -18.30%5.32M11.36%21.97M-20.31%4.87M-13.47%4.96M37.56%5.62M71.80%6.51M77.49%19.73M81.05%6.12M89.34%5.74M64.15%4.08M
Non-operating interest income -18.30%5.32M11.36%21.97M-20.31%4.87M-13.47%4.96M37.56%5.62M71.80%6.51M77.49%19.73M81.05%6.12M89.34%5.74M64.15%4.08M
Other net income (expense)
Income before tax -54.70%-87.17M-36.42%-263.7M-33.62%-78.22M-76.82%-86.42M3.94%-42.7M-36.02%-56.35M-34.28%-193.3M-39.53%-58.54M-32.16%-48.87M-83.12%-44.46M
Income tax 181.48%760K00744.44%760K0270K8K82K90K
Net income -54.70%-87.17M-36.62%-264.46M-33.60%-78.22M-76.53%-86.42M2.43%-43.46M-35.73%-56.35M-34.47%-193.57M-39.55%-58.55M-32.38%-48.96M-83.49%-44.55M
Net income continuous Operations -54.70%-87.17M-36.62%-264.46M-33.60%-78.22M-76.53%-86.42M2.43%-43.46M-35.73%-56.35M-34.47%-193.57M-39.55%-58.55M-32.38%-48.96M-83.49%-44.55M
Minority interest income
Net income attributable to the parent company -54.70%-87.17M-36.62%-264.46M-33.60%-78.22M-76.53%-86.42M2.43%-43.46M-35.73%-56.35M-34.47%-193.57M-39.55%-58.55M-32.38%-48.96M-83.49%-44.55M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -54.70%-87.17M-36.62%-264.46M-33.60%-78.22M-76.53%-86.42M2.43%-43.46M-35.73%-56.35M-34.47%-193.57M-39.55%-58.55M-32.38%-48.96M-83.49%-44.55M
Basic earnings per share -17.91%-0.79-5.90%-3.05-9.33%-0.82-53.73%-1.0326.76%-0.5211.84%-0.67-8.68%-2.882.60%-0.751.47%-0.67-57.78%-0.71
Diluted earnings per share -17.91%-0.79-5.90%-3.05-9.33%-0.82-53.73%-1.0326.76%-0.5211.84%-0.67-8.68%-2.882.60%-0.751.47%-0.67-57.78%-0.71
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes------
Market Insights
No. Symbol 20D % Chg
Sample Name
Sample Code
 +6.33%
Sample Name
Sample Code
 +4.40%
Sample Name
Sample Code
 +3.43%
4
United States Gasoline Fund Lp
UGA
+0.46%
5
United Sts 12 Month Oil Fd Lp Unit Ben Int
USL
-1.17%
View More
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +17.08%
Sample Name
Sample Code
 +16.18%
Sample Name
Sample Code
 +15.82%
4
Baidu
BIDU
+15.52%
5
Zai Lab
ZLAB
+13.31%
View More
Middle East conflict spreads to the stock market! How should investors respond?
Lebanon and Israel will implement a 10-day ceasefire! On the 16th, US President Trump stated that the next round of talks between the US and Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -